Jasper Therapeutics Inc

JSPR

Company Profile

  • Business description

    Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

  • Contact

    2200 Bridge Parkway
    Suite 102
    RedwoodCA94065
    USA

    T: +1 650 549-1400

    https://www.jaspertherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    64

Stocks News & Analysis

stocks

After Earnings, is Alphabet stock a buy, a sell, or fairly valued?

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
stocks

Moated ASX share crashes amid weak trading update

Bapcor signalled lower underlying profits for fiscal 2025, while an audit cast doubt on the firm’s past earnings.
stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,015.4048.700.54%
CAC 407,903.6846.320.59%
DAX 4024,255.4938.120.16%
Dow JONES (US)44,632.99204.57-0.46%
FTSE 1009,119.6316.69-0.18%
HKSE25,176.93347.52-1.36%
NASDAQ21,098.2980.29-0.38%
Nikkei 22540,654.7019.85-0.05%
NZX 50 Index12,855.9780.44-0.62%
S&P 5006,370.8618.91-0.30%
S&P/ASX 2008,756.4051.800.60%
SSE Composite Index3,615.726.010.17%

Market Movers